參考文獻(xiàn)/References:
[1] WANG L,YU W,YIN X,et al.Prevalence of osteoporosis and fracture in China:the China osteoporosis prevalence study[J/OL].JAMA network open,2021,4(8):e2121106[2022-09-25].https://pubmed.ncbi.nlm.nih.gov/34398202/.
[2] MALERBA F,BRUNI ERCOLE B,FLORIO R,et al.A quantitative bioassay to determine the inhibitory potency of NGF-TrkA antagonists[J].SLAS discov,2021,26(6):823-830.
[3] POOLE A J,FRIGOTTO L,SMITH M E,et al.A C-terminal cysteine residue is required for peptide-based inhibition of the NGF/TrkA interaction at nM concentrations:implications for peptide-based analgesics[J].Sci Rep,2019,9(1):930.
[4] LUISA R M,MARZIA S,LUIGI M,et al.Nerve growth factor:early studies and recent clinical trials[J].Curr Neuropharmacol,2018,16(10):1455-1465.
[5] YAMASHITA N.NGF signaling in endosomes[J].Adv Exp Med Biol,2021,1331:19-29.
[6] LIU Z,WU H,HUANG S.Role of NGF and its receptors in wound healing(review)[J].Exp Ther Med,2021,21(6):599.
[7] LORENZINI L,BALDASSARRO V A,STANZANI A,et al.Nerve growth factor:the first molecule of the neurotrophin family[J].Adv Exp Med Biol,2021,1331:3-10.
[8] BARKER P A,MANTYH P,ARENDT-NIELSEN L,et al.Nerve growth factor signaling and its contribution to pain[J].J Pain Res,2020,13:1223-1241.
[9] OBREJA O,RUKWIED R,NAGLER L,et al.Nerve growth factor locally sensitizes nociceptors in human skin[J].Pain,2018,159(3):416-426.
[10] MAGNUSDOTTIR R,GOHIN S,TER HEEGDE F,et al.Fracture-induced pain-like behaviours in a femoral fracture mouse model[J].Osteoporos int,2021,32(11):2347-2359.
[11] DENK F,BENNETT D L,MCMAHON S B.Nerve growth factor and pain mechanisms[J].Annu Rev Neurosci,2017,40:307-325.
[12] LIUQIN J,BIXING Y,YUN W,et al.Effect and mechanisms of sacral nerve stimulation on visceral hypersensitivity mediated by nerve growth factor[J].J Cell Mol Med,2019,23(12):8019-8024.
[13] CHUANG H H,PRESCOTT E D,KONG H,et al.Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition[J].Nature,2001,411(6840):957-962.
[14] SHU X,MENDELL L M.Acute sensitization by NGF of the response of small-diameter sensory neurons to capsaicin[J].J Neurophysiol,2001,86(6):2931-2938.
[15] JONAS R,KLUSCH A,SCHMELZ M,et al.Assessment of TTX-s and TTX-r action potential conduction along neurites of NGF and GDNF cultured porcine DRG somata[J].PLoS One,2015,10(9):e0139107[2022-9-25].https://pubmed.ncbi.nlm.nih.gov/26407014/.
[16] LIU B W,ZHANG J,HONG Y S,et al.NGF-induced nav1.7 upregulation contributes to chronic post-surgical pain by activating SGK1-dependent Nedd4-2 phosphorylation[J].Mol Neurobiol,2020,58(3):964-982.
[17] JIANG Y,TUAN R S.Role of NGF-TrkA signaling in calcification of articular chondrocytes[J].FASEB J,2019,33(9):10231-10239.
[18] TOMLINSON R E,LI Z,ZHANG Q,et al.NGF-TrkA signaling by sensory nerves coordinates the vascularization and ossification of developing endochondral bone[J].Cell Rep,2016,16(10):2723-2735.
[19] LI Z,MEYERS C A,CHANG L,et al.Fracture repair requires TrkA signaling by skeletal sensory nerves[J].J Clin Invest,2019,129(12):5137-5150.
[20] JIAN Q,LI Y,YIN Z Q.Rat BMSCs initiate retinal endogenous repair through NGF/TrkA signaling[J].Exp Eye Res,2015,132:34-47.
[21] TOMLINSON R E,LI Z,LI Z,et al.NGF-TrkA signaling in sensory nerves is required for skeletal adaptation to mechanical loads in mice[J].Proc Natl Acad Sci USA,2017,114(18):E3632-E3641.
[22] RIVERA K O,RUSSO F,BOILEAU R M,et al.Local injections of β-NGF accelerates endochondral fracture repair by promoting cartilage to bone conversion[J].Sci Rep,2020,10(1):22241.
[23] SEMIS H S,KANDEMIR F M,KAYNAR O,et al.The protective effects of hesperidin against paclitaxel-induced peripheral neuropathy in rats[J].Life sciences,2021,287:120104.
[24] HSU S T,YAO C H,HSU Y M,et al.Effects of taxol on regeneration in a rat sciatic nerve transection model[J].Sci Rep,2017,7:42280.
[25] GODINHO-MOTA J C M,MOTA J F,GONÇALVES L V,et al.Chemotherapy negatively impacts body composition, physical function and metabolic profile in patients with breast cancer[J].Clin Nutr,2021,40(5):3421-3428.
[26] SABSOVICH I,WEI T,GUO T Z,et al.Effect of anti-NGF antibodies in a rat tibia fracture model of complex regional pain syndrome type I[J].Pain,2008,138(1):47-60.
[27] KOEWLER N J,FREEMAN K T,BUUS R J,et al.Effects of a monoclonal antibody raised against nerve growth factor on skeletal pain and bone healing after fracture of the C57BL/6J mouse femur[J].J Bone Miner Res,2007,22(11):1732-1742.
[28] RAPP A E,KRONER J,BAUR S,et al.Analgesia via blockade of NGF/TrkA signaling does not influence fracture healing in mice[J].J Orthop Res,2015,33(8):1235-1241.
[29] INOUE S,TAKITO J,NAKAMURA M.Site-specific fracture healing:comparison between diaphysis and metaphysis in the mouse long bone[J].Int J Mol Sci,2021,22(17):9299.
[30] SEKIGUCHI H,INOUE G,SHOJI S,et al.Expression of nerve growth factor in the callus during fracture healing in a fracture model in aged mice[J].Biomed Mater Eng,2022,33(2):131-137.
[31] ATKINSON T J,FUDIN J.Nonsteroidal antiinflammatory drugs for acute and chronic pain[J].Phys Med Rehabil Clin N Am,2020,31(2):219-231.
[32] WHEATLEY B M,NAPPO K E,CHRISTENSEN D L,et al.Effect of NSAIDs on bone healing rates:a Meta-analysis[J].J Am Acad Orthop Surg,2019,27(7):e330-e336.
[33] GEORGE M D,BAKER J F,LEONARD C E,et al.Risk of nonunion with nonselective NSAIDs,COX-2 Inhibitors,and Opioids[J].J Bone Joint Surg Am,2020,102(14):1230-1238.
[34] STEIN C.Pain inhibition by opioids-new concepts[J].Schmerz,2019,33(4):295-302.
[35] COLUZZI F,SCERPA M S,CENTANNI M.The effect of opiates on bone formation and bone healing[J].Curr Osteoporos Rep,2020,18(3):325-335.
[36] ENOMOTO M,MANTYH P W,MURRELL J,et al.Anti-nerve growth factor monoclonal antibodies for the control of pain in dogs and cats[J].Vet Rec,2019,184(1):23.
[37] OO W M,HUNTER D J.Nerve growth factor(NGF)inhibitors and related agents for chronic musculoskeletal pain:a comprehensive review[J].BioDrugs,2021,35(6):611-641.
[38] BANNWARTH B,KOSTINE M.Nerve growth factor an-tagonists:is the future of monoclonal antibodies becoming clearer?[J].Drugs,2017,77(13):1377-1387.
[39] HOCHBERG M C,TIVE L A,ABRAMSON S B,et al.When is osteonecrosis not osteonecrosis?:Adjudication of reported serious adverse joint events in the tanezumab clinical development program[J].Arthritis Rheumatol,2016,68(2):382-391.
[40] OGA S,GOTO K,SAKAMOTO J,et al.Mechanisms underlying immobilization-induced muscle pain in rats[J].Muscle Nerve,2020,61(5):662-670.
[41] ASO K,SHAHTAHERI S M,HILL R,et al.Contribution of nerves within osteochondral channels to osteoarthritis knee pain in humans and rats[J].Osteoarthritis Cartilage,2020,28(9):1245-1254.
[42] LOUDON P,SIEBENGA P,GORMAN D,et al.Demonstration of an anti-hyperalgesic effect of a novel pan-Trk inhibitor PF-06273340 in a battery of human evoked pain models[J].Br J Clinical Pharmacol,2018,84(2):301-309.
[43] WALSH D A,NEOGI T.A tale of two TrkA inhibitor trials:same target,divergent results[J].Osteoarthritis Cartilage,2019,27(11):1575-1577.
[44] OWOLABI J B,RIZKALLA G,TEHIM A, et al.Characterization of antiallodynic actions of ALE-0540,a novel nerve growth factor receptor antagonist,in the rat[J].J Pharmacol Exp Ther,1999,289(3):1271-1276.
[45] UGOLINI G,MARINELLI S,COVACEUSZACH S,et al.The function neutralizing anti-TrkA antibody MNAC13 reduces inflammatory and neuropathic pain [J].Proc Natl Acad Sci USA, 2007, 104(8): 2985-2990.
[46] 葛欽文,施振宇,凌厚福,等.益腎調(diào)髓方對膝骨關(guān)節(jié)炎小鼠軟骨下骨骨代謝及疼痛的影響[J].中華中醫(yī)藥雜志,2022,37(10):5658-5663.
[47] 尹濤.經(jīng)皮神經(jīng)電刺激配合黃芪桂枝五物湯治療髖臼骨折、髖關(guān)節(jié)脫位所致坐骨神經(jīng)損傷的療效及對患者血清神經(jīng)營養(yǎng)因子的影響[J].河北中醫(yī),2018,40(2):253-255.
[48] 劉宗海,李俊光,孫大川.防旋轉(zhuǎn)股骨近端髓內(nèi)釘聯(lián)合術(shù)后中藥外敷治療股骨轉(zhuǎn)子間骨折的臨床效果研究[J].中國中西醫(yī)結(jié)合外科雜志,2020,26(5):892-896.
[49] 李學(xué)姍,段雪劍,白曉梅,等.四黃軟膏外敷緩解鼠神經(jīng)生長因子注射疼痛的效果觀察[J].中西醫(yī)結(jié)合護(hù)理(中英文),2019,5(2):71-73.